Item 5. Other Information
Item 5. Other Information.
None.
27
Table of Contents
Item 6. Exhibits.
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q
are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference.
Exhibit
Number
Incorporated by Reference
Filed
Herewith
Description
Form
Date
Number
31.1*
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
31.2*
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
32.1*
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
32.2*
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
101
The following materials from the Company’s Quarterly Report on Form 10-Q
for the quarter ended June 30, 2020, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Balance Sheets as of June 30, 2020 (unaudited) and December 31, 2019; (ii) the Condensed Balance Sheets as of June 30, 2020 (unaudited) and December 31, 2019; (ii) the Condensed Statements of Operations for the three and six months ended June 30, 2020 and 2019 (unaudited); (iv) the Condensed Statements of Stockholders’ Equity as of June 30, 2020 and June 30, 2019 (unaudited); (v) the Condensed Statements of Cash Flows for the six months ended June 30, 2020 and 2019 (unaudited); and (vi) the notes to Unaudited Interim Condensed Financial Statements.
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
*
This certification is deemed not filed for purpose of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act
28
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HCW Biologics Inc.
Date: August 13, 2021
By:
/s/ Hing C. Wong
Hing C. Wong
Chief Executive Officer
(Principal Executive Officer)
Date: August 13, 2021
By:
/s/ Rebecca Byam
Rebecca Byam
Chief Financial Officer
(Principal Financial and Accounting Officer)
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.